Changjin FU
Inventor
Stats
- 2 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 2 US Patents Issued
- 8 US Applications Filed
- 2 Total Citation Count
- Apr 28, 2022 Most Recent Filing
- Nov 24, 2013 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| JIANGSU ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. | 2
| 2013
|
| ATOM BIOSCIENCE AND PHARMACEUTICAL CO., LTD. (CN) | 2
| 2013
|
Inventor Addresses
| Address | Duration |
|---|---|
| Jiangsu, CN | Jun 26, 18 - Jun 26, 18 |
| Suzhou, CN | Aug 12, 21 - Aug 08, 24 |
| Zhenjiang, CN | Oct 31, 17 - Aug 20, 24 |
| Zhenjiang, Jiangsu, CN | Oct 15, 15 - May 17, 18 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 4 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 6 |
| C07D: | HETEROCYCLIC COMPOUNDS | 8 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| RE50083 | 2024 | URAT1 inhibitor and use thereof | 0 |
| 2024/0262,808 | 2024 | XANTHINE OXIDASE INHIBITOR | 0 |
| 2022/0041,593 | 2022 | SYNTHESIS FOR 3-BROMO-5-(2-ETHYLIMIDAZO[1, 2-ALPHA]PYRIDINE- 3-CARBONYL)-2-HYDROXYBENZONITRILE | 0 |
| 2021/0246,126 | 2021 | COMPOUND FOR TREATMENT OR PREVENTION OF LIVER DISEASES | 0 |
| 10875865 | 2020 | URAT1 inhibitor and use thereof | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.